United Arab Emirates-based drugmaker Neopharma and ASKA Pharmaceuticals of Tokyo entered a joint venture to build a $53 million (₹350-crore) pharmaceutical manufacturing facility to be operated by Neopharma subsidiary Omnicare Drugs India in Visakhapatnam